4D Pharma PLC (LBPS)

US35085K1097 - ADR

1.65  +0.04 (+2.48%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
210K530K
152.38%		520K
-1.89%		16.362MN/AN/A
EBITDA
YoY % growth
-29.36M
-5.20%		-29.34M
0.07%		-25.54M
12.95%		-24.24M
EBIT
YoY % growth
-30.64M
-5.22%		-30.54M
0.33%		-26.52M
13.16%		-17.17MN/AN/A
Operating Margin
-14,590.48%-5,762.26%-5,100.00%-104.94%N/AN/A
EPS
YoY % growth
N/AN/AN/A-1.18

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q2 2019
Q2Q % growth		 -1.47 -1.13-0.33-29.49%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in GBP, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q2 2019
Q2Q % growth		 %
Q4 2018
Q2Q % growth		 %
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A